Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.5393
+0.0008 (0.15%)
Aug 25, 2025, 12:24 PM - Market open

RVPH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
Net Income
-27.11-29.92-39.26-28.26-8.52-3.78
Upgrade
Depreciation & Amortization
-----0
Upgrade
Stock-Based Compensation
2.221.633.410.180.15-
Upgrade
Other Operating Activities
-0.13-0.720.240.19-1.592.05
Upgrade
Change in Accounts Payable
-0.092.290.333.01-0.50.78
Upgrade
Change in Other Net Operating Assets
-1.43-6.836.965.92-0.2-3.1
Upgrade
Operating Cash Flow
-26.55-33.54-28.32-18.96-10.67-4.07
Upgrade
Short-Term Debt Issued
-0.980.67--3.11
Upgrade
Total Debt Issued
0.560.980.67--3.11
Upgrade
Short-Term Debt Repaid
--0.52-0.67---
Upgrade
Total Debt Repaid
-0.66-0.52-0.67---
Upgrade
Net Debt Issued (Repaid)
-0.090.46---3.11
Upgrade
Issuance of Common Stock
30.8323.1933.177.7931.69.72
Upgrade
Financing Cash Flow
30.7323.6533.177.7931.612.83
Upgrade
Net Cash Flow
4.19-9.894.85-11.1720.938.76
Upgrade
Cash Interest Paid
0.020.020.03--0.33
Upgrade
Cash Income Tax Paid
000.02-00
Upgrade
Levered Free Cash Flow
-16.07-21.54-14.01-8.54-6.87-4.15
Upgrade
Unlevered Free Cash Flow
-16.05-21.52-13.99-8.54-6.87-3.24
Upgrade
Change in Working Capital
-1.52-4.547.288.93-0.7-2.33
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q